{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:47:40Z","timestamp":1791895660516,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.schres.2026.09.027","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:59:55Z","timestamp":1790121595000},"page":"637-642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Low-dose versus standard-dose antipsychotic treatment in first-episode schizophrenia: A secondary analysis of EUFEST data"],"prefix":"10.1016","volume":"297","author":[{"given":"Nobuyuki","family":"Nomura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyoshi","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.schres.2026.09.027_bb0005","doi-asserted-by":"crossref","first-page":"B16","DOI":"10.1016\/j.clinthera.2011.11.016","article-title":"Quantifying clinical relevance in the treatment of schizophrenia","volume":"33","author":"Correll","year":"2011","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.schres.2026.09.027_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/npjschz.2014.5","article-title":"Predictors of outcome in early-onset psychosis: a systematic review","volume":"1","author":"D\u00edaz-Caneja","year":"2015","journal-title":"NPJ Schizophr."},{"issue":"11","key":"10.1016\/j.schres.2026.09.027_bb0015","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.158.11.1835","article-title":"Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia","volume":"158","author":"Gitlin","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2026.09.027_bb0020","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/15622975.2012.696143","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance","volume":"13","author":"Hasan","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.09.027_bb0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0269881105051539","article-title":"Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness","volume":"19","author":"Honer","year":"2005","journal-title":"J. Psychopharmacol."},{"issue":"9618","key":"10.1016\/j.schres.2026.09.027_bb0030","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.schres.2026.09.027_bb0035","doi-asserted-by":"crossref","first-page":"994","DOI":"10.4088\/JCP.v62n1214c","article-title":"A pilot double-blind, dose-comparison study of risperidone in drug-naive, first-episode schizophrenia","volume":"62","author":"Lane","year":"2001","journal-title":"J. Clin. Psychiatry"},{"issue":"9831","key":"10.1016\/j.schres.2026.09.027_bb0040","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis","volume":"379","author":"Leucht","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.schres.2026.09.027_bb0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/CIRCULATIONAHA.114.008779","article-title":"Association between antipsychotic use and risk of acute myocardial infarction: a nationwide case-crossover study","volume":"130","author":"Lin","year":"2014","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.schres.2026.09.027_bb0050","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.1017\/S0033291723000429","article-title":"Guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis: a 2-year randomized controlled trial with a naturalistic cohort","volume":"53","author":"Liu","year":"2023","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.schres.2026.09.027_bb0055","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4088\/JCP.14m09540","article-title":"Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study","volume":"77","author":"Mayoral-van Son","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.027_bb0060","article-title":"Very low-dose risperidone in first-episode psychosis: a safe and effective way to initiate treatment","volume":"2011","author":"McGorry","year":"2011","journal-title":"Schizophr. Res. Treat."},{"issue":"10","key":"10.1016\/j.schres.2026.09.027_bb0065","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4088\/JCP.v63n1006","article-title":"Risperidone, 2 mg\/day vs. 4 mg\/day, in first-episode, acutely psychotic patients: treatment efficacy and effects on fine motor functioning","volume":"63","author":"Merlo","year":"2002","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2026.09.027_bb0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1192\/bjp.bp.116.182683","article-title":"Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?","volume":"209","author":"Murray","year":"2016","journal-title":"Br. J. Psychiatry"},{"issue":"13","key":"10.1016\/j.schres.2026.09.027_bb0075","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1017\/S0033291724001910","article-title":"Deprescribing antipsychotics in patients with schizophrenia: findings from a specialized clinic","volume":"54","author":"N\u00f8stdal","year":"2024","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.schres.2026.09.027_bb0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1017\/S1461145704004262","article-title":"A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis","volume":"7","author":"Oosthuizen","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2026.09.027_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c4245","article-title":"Antipsychotic drugs and risk of venous thromboembolism: nested case-control study","volume":"341","author":"Parker","year":"2010","journal-title":"BMJ"},{"issue":"01","key":"10.1016\/j.schres.2026.09.027_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S1461145713001053","article-title":"Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors","volume":"17","author":"P\u00e9rez-Iglesias","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.schres.2026.09.027_bb0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.schres.2026.09.027_bb0100","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/schbul\/sbab063","article-title":"Long-term continuity of antipsychotic treatment for schizophrenia: a nationwide study","volume":"47","author":"Rubio","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.09.027_bb0105","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.schres.2021.07.040","article-title":"Antipsychotic treatment strategies for acute phase and treatment resistance in schizophrenia: a systematic review of the guidelines and algorithms","volume":"236","author":"Shimomura","year":"2021","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2026.09.027_bb0110","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jamapsychiatry.2025.2525","article-title":"Early dose reduction or discontinuation vs maintenance antipsychotics after first psychotic episode remission: a randomized clinical trial","volume":"83","author":"Sommer","year":"2026","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.09.027_bb0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/wps.20699","article-title":"20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)","volume":"19","author":"Taipale","year":"2020","journal-title":"World Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2026.09.027_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2804","article-title":"Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first-episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms","volume":"36","author":"Takeuchi","year":"2021","journal-title":"Hum. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.schres.2026.09.027_bb0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/eip.12251","article-title":"Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications","volume":"10","author":"Tek","year":"2016","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.027_bb0115","series-title":"A Package for Survival Analysis in R","author":"Therneau","year":"2024"},{"key":"10.1016\/j.schres.2026.09.027_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-11-197","article-title":"Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?","volume":"11","author":"Ulcickas Yood","year":"2011","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.09.027_bb0140","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/schbul\/sbac001","article-title":"Antipsychotic-induced weight gain: dose-response meta-analysis of randomized controlled trials","volume":"48","author":"Wu","year":"2022","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.09.027_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.113098","article-title":"Dose-dependent effects of antipsychotics on efficacy and adverse effects in schizophrenia","volume":"402","author":"Yoshida","year":"2021","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.schres.2026.09.027_bb0150","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.euroneuro.2017.06.011","article-title":"How well do patients with a first episode of schizophrenia respond to antipsychotics: a systematic review and meta-analysis","volume":"27","author":"Zhu","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2\u20133","key":"10.1016\/j.schres.2026.09.027_bb0155","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.schres.2013.08.001","article-title":"Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review","volume":"152","author":"Zipursky","year":"2014","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099642600321X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099642600321X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:03:29Z","timestamp":1791893009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099642600321X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":31,"alternative-id":["S092099642600321X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.09.027","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose versus standard-dose antipsychotic treatment in first-episode schizophrenia: A secondary analysis of EUFEST data","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}